Aspect Imaging

Company Overview

Snapshot

Founded in January 2007 by Uri Rapoport, Aspect Imaging operates with 51–200 employees. The company has raised $50,000,000 across two funding rounds from two investors. In July 2017, Aspect Imaging announced FDA clearance for its Embrace Neonatal MRI System, marking a significant regulatory milestone for its medical imaging technology.

Business overview

Aspect Imaging specializes in the design and development of compact MRI imaging and NMR systems, utilizing permanent magnets at 1 and 1.5 Tesla. The company's technology platform underpins a diverse product portfolio catering to medical, preclinical research, oil and gas, and advanced industrial markets. Key medical applications include the Embrace Neonatal MRI system and the WristView point-of-care hand and wrist MRI system, both in full production, alongside a dedicated Stroke MRI for emergency rooms under development. For preclinical research, the M-series compact MRI supports various in vivo and ex vivo applications, while industrial solutions like Flowscan and AI-60 NMR are used for rheological analysis and real-time stream analysis of dense materials.

Strategic signal

In September 2018, Aspect Imaging partnered with Brightonix Imaging to showcase the SimPET Simultaneous Preclinical PET/MRI Insert at WMIC 2018. This collaboration highlights Aspect Imaging's commitment to advancing preclinical imaging capabilities through integrated solutions, signaling ongoing innovation and strategic partnerships within the medical and research technology sectors.

Company Intelligence Q&A

What is Aspect Imaging's core focus?

Aspect Imaging designs and develops compact MRI imaging and NMR systems for preclinical, medical, and advanced industrial applications, utilizing permanent magnets at 1 and 1.5 Tesla.

When did Aspect Imaging receive FDA clearance for its Embrace Neonatal MRI System?

In July 2017, Aspect Imaging announced FDA clearance for its Embrace Neonatal MRI System, the first dedicated neonatal MRI system for the NICU.

What significant regulatory approval did Aspect Imaging receive for its Embrace Neonatal MRI System in Europe?

In November 2017, Aspect Imaging received CE Mark approval for its Embrace Neonatal MRI System, enabling its use in the NICU within European markets.

What was a key partnership announced by Aspect Imaging in 2018?

In September 2018, Aspect Imaging and Brightonix Imaging showcased the SimPET Simultaneous Preclinical PET/MRI Insert at WMIC 2018, demonstrating a collaborative effort in advanced imaging solutions.

When did Aspect Imaging announce FDA clearance for its M2 Compact MRI System?

In April 2013, Aspect Imaging announced FDA clearance for its M2 Compact MRI System for clinical imaging of the wrist.